Reply letter to "Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal"

被引：1
|
作者：
Hadigal, Sanjay [1 ]
Colombo, Laura [2 ]
Cook, Joseph [3 ]
机构：
[1] Viatris, Dept Med Affairs, Bangalore, India
[2] Viatris, Dept Med Affairs, Monza, Italy
[3] Viatris, Dept Med Affairs, Canonsburg, PA USA
来源：
JOURNAL OF MEDICAL ECONOMICS | 2023年 / 26卷 / 01期
关键词：
D O I：
10.1080/13696998.2023.2237379
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：933 / 934
页数：2
相关论文
共 50 条
  • [41] Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
    Quinn, Emma
    Jit, Mark
    Newall, Anthony T.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (03) : 425 - 435
  • [42] Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France
    Paccalin, Marc
    Gavazzi, Gaetan
    Berkovitch, Quentin
    Leleu, Henri
    Moreau, Romain
    Ciglia, Emanuele
    Burlet, Nansa
    Mould-Quevedo, Joaquin F.
    VACCINES, 2024, 12 (06)
  • [43] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE FOR NATIONAL IMMUNIZATION PROGRAM IN SOUTH KOREA
    Shin, G.
    Choi, S.
    Lim, J.
    Kang, D.
    Bae, E.
    Choi, M. J.
    NhoJy
    Song, J. Y.
    Cheong, H. J.
    Yun, J. W.
    Kim, Y.
    Lim, E.
    VALUE IN HEALTH, 2017, 20 (09) : A789 - A789
  • [44] Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
    Song, Youngji
    Shim, Eunha
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [45] Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
    Watle, Sara Viksmoen
    Naess, Lisbeth Meyer
    Tunheim, Gro
    Caugant, Dominique A.
    Wisloff, Torbjorn
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2777 - 2787
  • [46] Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
    Zeevat, Florian
    Crepey, Pascal
    Dolk, F. Christiaan K.
    Postma, Arjan J.
    Breeveld-Dwarkasing, Vidya N. A.
    Postma, Maarten J.
    VALUE IN HEALTH, 2021, 24 (01) : 3 - 10
  • [47] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINATION IN THE DUTCH NATIONAL INFLUENZA PREVENTION PROGRAM
    Zeevat, F.
    Crepey, P.
    Dolk, C.
    Postma, A. J.
    Breeveld-Dwarkasing, V. N. A.
    Postma, M.
    VALUE IN HEALTH, 2019, 22 : S647 - S647
  • [48] Cost-effectiveness of universal influenza vaccination in a pregnant population
    Roberts, Scott
    Hollier, Lisa M.
    Sheffield, Jeanne
    Laibl, Vanessa
    Wendel, George D., Jr.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (06): : 1323 - 1329
  • [49] The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany
    Kohli, Michele A.
    Maschio, Michael
    Cartier, Shannon
    Mould-Quevedo, Joaquin
    Fricke, Frank-Ulrich
    VACCINES, 2022, 10 (09)
  • [50] Cost-Effectiveness of Vaccination of Older Adults with an MF59®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden
    Jacob, Jorge
    Biering-Sorensen, Tor
    Holger Ehlers, Lars
    Edwards, Christina H.
    Mohn, Kristin Greve-Isdahl
    Nilsson, Anna
    Hjelmgren, Jonas
    Ma, Wenkang
    Sharma, Yuvraj
    Ciglia, Emanuele
    Mould-Quevedo, Joaquin
    VACCINES, 2023, 11 (04)
12345